May 11 (Reuters) - Avita Medical Inc RCEL.O :
* AVITA MEDICAL REPORTS FIRST QUARTER FINANCIAL RESULTS AND
AFFIRMS FULL YEAR GUIDANCE
* QTRLY TOTAL REVENUE, WHICH INCLUDES BARDA REVENUE, OF
$10.6
MILLION, UP 40%
* QTRLY LOSS PER SHARE $0.37
* Q1 EARNINGS PER SHARE VIEW $-0.25, REVENUE VIEW $10.3
MILLION --
REFINITIV IBES DATA
* COMMERCIAL REVENUE, WHICH EXCLUDES BARDA REVENUE, FOR Q2
2023 IS
EXPECTED TO BE IN RANGE OF $10.7 TO $11.7 MILLION
Source text for Eikon: ID:nGNX8gShc1
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com;))